This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Baxter Healthcare Sa, Baxter International Inc., Biolinq Incorporated. Active years: 2025-2026.
Company Filing History:
2 out of 1,198 
2 out of 2,530 
2 out of 41 Years Active: 2025-2026
Title: Innovations of James Patrick Mccanna in Microneedle Technology
Introduction
James Patrick Mccanna is an accomplished inventor based in Pleasanton, CA (US). He has made significant contributions to the field of microneedle technology, particularly in the development of methods for achieving isolated electrical interfaces. His work has the potential to advance the capabilities of electrochemical biosensors.
Latest Patents
Mccanna holds a patent titled "Methods for achieving an isolated electrical interface between an anterior surface of a microneedle structure and a posterior surface of a support structure." This patent describes a method for circumscribing an insulating barrier region around a singular conductive microneedle structure or a plurality of conductive microneedle structures adhered to a fixed substrate. The method aims to spatially define a conduit for routing electrical signals from the surface of the microneedle or microneedles to the posterior surface of the substrate. This innovation is crucial for enhancing the functionality of microneedle-based electrochemical biosensors.
Career Highlights
Mccanna is currently associated with Biolinq Incorporated, where he continues to push the boundaries of microneedle technology. His work is characterized by a commitment to improving biosensor designs and their applications in various fields, including healthcare.
Collaborations
Mccanna has collaborated with notable colleagues such as Joshua Ray Windmiller and Jared Rylan Tangney. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
James Patrick Mccanna's contributions to microneedle technology exemplify the impact of innovative thinking in the field of biosensors. His patent and ongoing work at Biolinq Incorporated highlight the importance of advancements in this area.